US Stock MarketDetailed Quotes

United Therapeutics (UTHR)

Watchlist
  • 571.730
  • -3.040-0.53%
Close Apr 10 16:00 ET
  • 571.730
  • 0.0000.00%
Post 17:47 ET
25.06BMarket Cap20.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

United Therapeutics (UTHR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
10.61%3.18B
7.38%790.2M
6.76%799.5M
11.71%798.6M
17.22%794.4M
23.63%2.88B
19.72%735.9M
22.89%748.9M
19.85%714.9M
33.70%677.7M
Operating revenue
10.61%3.18B
7.32%807.6M
6.62%792.6M
11.70%793.1M
17.22%794.4M
23.63%2.88B
22.42%752.5M
21.99%743.4M
19.03%710M
33.70%677.7M
Cost of revenue
24.12%384.4M
36.23%103.4M
21.42%100.9M
12.60%87.6M
26.89%92.5M
20.27%309.7M
6.90%75.9M
18.54%83.1M
21.37%77.8M
39.39%72.9M
Gross profit
8.98%2.8B
4.06%686.8M
4.93%698.6M
11.60%711M
16.05%701.9M
24.04%2.57B
21.39%660M
23.46%665.8M
19.67%637.1M
33.04%604.8M
Operating expense
14.42%1.28B
11.14%329.3M
20.07%309.3M
2.40%324.8M
28.41%319.1M
26.49%1.12B
4.48%296.3M
21.34%257.6M
44.84%317.2M
46.00%248.5M
Selling and administrative expenses
14.48%731.1M
16.80%189.8M
17.98%181.8M
7.43%190.8M
17.80%170.1M
33.85%638.6M
22.92%162.5M
20.77%154.1M
36.62%177.6M
65.41%144.4M
-Selling and marketing expense
23.16%118.6M
21.11%32.7M
36.71%28.3M
22.05%31M
14.66%26.6M
17.73%96.3M
12.03%27M
0.00%20.7M
26.37%25.4M
37.28%23.2M
-General and administrative expense
12.94%612.5M
15.94%157.1M
15.07%153.5M
4.99%159.8M
18.40%143.5M
37.19%542.3M
25.35%135.5M
24.79%133.4M
38.49%152.2M
72.16%121.2M
Research and development costs
14.35%550M
4.26%139.5M
23.19%127.5M
-4.01%134M
43.13%149M
17.89%481M
-11.62%133.8M
22.20%103.5M
56.85%139.6M
25.57%104.1M
Operating profit
4.77%1.52B
-1.70%357.5M
-4.63%389.3M
20.73%386.2M
7.44%382.8M
22.21%1.45B
39.83%363.7M
24.83%408.2M
2.07%319.9M
25.28%356.3M
Net non-operating interest income expense
10.44%172.5M
-3.14%40.1M
9.32%43.4M
27.17%44M
11.11%45M
51.06%156.2M
15.32%41.4M
33.67%39.7M
54.46%34.6M
162.99%40.5M
Non-operating interest income
-3.57%192M
-12.37%43.2M
-6.83%46.4M
11.04%51.3M
-5.02%51.1M
22.37%199.1M
-3.33%49.3M
9.93%49.8M
24.19%46.2M
84.25%53.8M
Non-operating interest expense
-54.55%19.5M
-60.76%3.1M
-70.30%3M
-37.07%7.3M
-54.14%6.1M
-27.66%42.9M
-47.68%7.9M
-35.26%10.1M
-21.62%11.6M
-3.62%13.3M
Other net income (expense)
137.06%24.2M
639.53%46.4M
108.94%5.3M
-2,825.00%-21.8M
-338.89%-4.3M
-366.43%-65.3M
-1,333.33%-8.6M
-1,110.20%-59.3M
233.33%800K
122.78%1.8M
Special income (charges)
65.26%-24.7M
86.67%-800K
98.77%-800K
---21.7M
----
---71.1M
---6M
---65.1M
--0
----
-Less:Impairment of capital assets
--21.7M
--0
--0
--21.7M
----
--0
--0
--0
--0
----
-Less:Other special charges
-95.78%3M
-86.67%800K
-98.77%800K
----
----
--71.1M
--6M
--65.1M
----
----
-Write off
----
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
743.10%48.9M
1,915.38%47.2M
5.17%6.1M
-112.50%-100K
-338.89%-4.3M
141.43%5.8M
-333.33%-2.6M
218.37%5.8M
233.33%800K
122.78%1.8M
Income before tax
11.36%1.71B
11.98%444M
12.71%438M
14.95%408.4M
6.25%423.5M
20.77%1.54B
34.22%396.5M
10.46%388.6M
6.00%355.3M
36.55%398.6M
Income tax
10.26%379.2M
-16.28%79.7M
24.91%99.3M
28.11%98.9M
10.11%101.3M
18.79%343.9M
21.58%95.2M
-5.58%79.5M
1.58%77.2M
80.39%92M
Net income
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
Net income continuous Operations
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
Minority interest income
Net income attributable to the parent company
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
Basic earnings per share
13.96%30.13
24.78%8.41
11.54%7.73
9.58%6.86
10.12%7.18
25.67%26.44
45.89%6.74
21.37%6.93
13.20%6.26
25.38%6.52
Diluted earnings per share
13.07%27.86
24.39%7.7
12.05%7.16
9.57%6.41
7.46%6.63
24.38%24.64
41.97%6.19
18.77%6.39
11.64%5.85
26.95%6.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 10.61%3.18B7.38%790.2M6.76%799.5M11.71%798.6M17.22%794.4M23.63%2.88B19.72%735.9M22.89%748.9M19.85%714.9M33.70%677.7M
Operating revenue 10.61%3.18B7.32%807.6M6.62%792.6M11.70%793.1M17.22%794.4M23.63%2.88B22.42%752.5M21.99%743.4M19.03%710M33.70%677.7M
Cost of revenue 24.12%384.4M36.23%103.4M21.42%100.9M12.60%87.6M26.89%92.5M20.27%309.7M6.90%75.9M18.54%83.1M21.37%77.8M39.39%72.9M
Gross profit 8.98%2.8B4.06%686.8M4.93%698.6M11.60%711M16.05%701.9M24.04%2.57B21.39%660M23.46%665.8M19.67%637.1M33.04%604.8M
Operating expense 14.42%1.28B11.14%329.3M20.07%309.3M2.40%324.8M28.41%319.1M26.49%1.12B4.48%296.3M21.34%257.6M44.84%317.2M46.00%248.5M
Selling and administrative expenses 14.48%731.1M16.80%189.8M17.98%181.8M7.43%190.8M17.80%170.1M33.85%638.6M22.92%162.5M20.77%154.1M36.62%177.6M65.41%144.4M
-Selling and marketing expense 23.16%118.6M21.11%32.7M36.71%28.3M22.05%31M14.66%26.6M17.73%96.3M12.03%27M0.00%20.7M26.37%25.4M37.28%23.2M
-General and administrative expense 12.94%612.5M15.94%157.1M15.07%153.5M4.99%159.8M18.40%143.5M37.19%542.3M25.35%135.5M24.79%133.4M38.49%152.2M72.16%121.2M
Research and development costs 14.35%550M4.26%139.5M23.19%127.5M-4.01%134M43.13%149M17.89%481M-11.62%133.8M22.20%103.5M56.85%139.6M25.57%104.1M
Operating profit 4.77%1.52B-1.70%357.5M-4.63%389.3M20.73%386.2M7.44%382.8M22.21%1.45B39.83%363.7M24.83%408.2M2.07%319.9M25.28%356.3M
Net non-operating interest income expense 10.44%172.5M-3.14%40.1M9.32%43.4M27.17%44M11.11%45M51.06%156.2M15.32%41.4M33.67%39.7M54.46%34.6M162.99%40.5M
Non-operating interest income -3.57%192M-12.37%43.2M-6.83%46.4M11.04%51.3M-5.02%51.1M22.37%199.1M-3.33%49.3M9.93%49.8M24.19%46.2M84.25%53.8M
Non-operating interest expense -54.55%19.5M-60.76%3.1M-70.30%3M-37.07%7.3M-54.14%6.1M-27.66%42.9M-47.68%7.9M-35.26%10.1M-21.62%11.6M-3.62%13.3M
Other net income (expense) 137.06%24.2M639.53%46.4M108.94%5.3M-2,825.00%-21.8M-338.89%-4.3M-366.43%-65.3M-1,333.33%-8.6M-1,110.20%-59.3M233.33%800K122.78%1.8M
Special income (charges) 65.26%-24.7M86.67%-800K98.77%-800K---21.7M-------71.1M---6M---65.1M--0----
-Less:Impairment of capital assets --21.7M--0--0--21.7M------0--0--0--0----
-Less:Other special charges -95.78%3M-86.67%800K-98.77%800K----------71.1M--6M--65.1M--------
-Write off ----------------------0----------------
Other non- operating income (expenses) 743.10%48.9M1,915.38%47.2M5.17%6.1M-112.50%-100K-338.89%-4.3M141.43%5.8M-333.33%-2.6M218.37%5.8M233.33%800K122.78%1.8M
Income before tax 11.36%1.71B11.98%444M12.71%438M14.95%408.4M6.25%423.5M20.77%1.54B34.22%396.5M10.46%388.6M6.00%355.3M36.55%398.6M
Income tax 10.26%379.2M-16.28%79.7M24.91%99.3M28.11%98.9M10.11%101.3M18.79%343.9M21.58%95.2M-5.58%79.5M1.58%77.2M80.39%92M
Net income 11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M
Net income continuous Operations 11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M
Minority interest income
Net income attributable to the parent company 11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M
Basic earnings per share 13.96%30.1324.78%8.4111.54%7.739.58%6.8610.12%7.1825.67%26.4445.89%6.7421.37%6.9313.20%6.2625.38%6.52
Diluted earnings per share 13.07%27.8624.39%7.712.05%7.169.57%6.417.46%6.6324.38%24.6441.97%6.1918.77%6.3911.64%5.8526.95%6.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -